Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery

Overview[ - collapse ][ - ]

Purpose The purpose of this study is to learn if apixaban can prevent blood clots in the leg (deep vein thrombosis [DVT]) and lung (pulmonary embolism [PE] that sometimes occur after hip replacement surgery and to learn how apixaban compares to enoxaparin (Lovenox®) for preventing these clots. The safety of apixaban will also be studied
ConditionDeep Vein Thrombosis
Pulmonary Embolism
InterventionDrug: Enoxaparin + Placebo
Drug: Apixaban + Placebo
PhasePhase 3
SponsorBristol-Myers Squibb
Responsible PartyBristol-Myers Squibb
ClinicalTrials.gov IdentifierNCT00423319
First ReceivedJanuary 17, 2007
Last UpdatedMarch 18, 2014
Last verifiedMarch 2014

Tracking Information[ + expand ][ + ]

First Received DateJanuary 17, 2007
Last Updated DateMarch 18, 2014
Start DateMarch 2007
Estimated Primary Completion DateSeptember 2009
Current Primary Outcome MeasuresA combination of asymptomatic and symptomatic DVT, non-fatal PE and all-cause death [Time Frame: after 35 days of treatment] [Designated as safety issue: No]
Current Secondary Outcome Measures
  • Combined endpoints: Proximal DVT, non-fatal PE, and VTE-related death [Time Frame: after 35 days of treatment] [Designated as safety issue: No]
  • Major & non-major bleeding events [Time Frame: upon occurrence] [Designated as safety issue: Yes]

Descriptive Information[ + expand ][ + ]

Brief TitleStudy of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery
Official TitleA Phase 3 Randomized, Double-Blind, Active-Controlled, Parallel-Group, Multi-Center Study to Evaluate the Safety and Efficacy of Apixaban in Subjects Undergoing Elective Total Hip Replacement Surgery
Brief Summary
The purpose of this study is to learn if apixaban can prevent blood clots in the leg (deep
vein thrombosis [DVT]) and lung (pulmonary embolism [PE] that sometimes occur after hip
replacement surgery and to learn how apixaban compares to enoxaparin (Lovenox®) for
preventing these clots. The safety of apixaban will also be studied
Detailed DescriptionNot Provided
Study TypeInterventional
Study PhasePhase 3
Study DesignAllocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention
Condition
  • Deep Vein Thrombosis
  • Pulmonary Embolism
InterventionDrug: Enoxaparin + Placebo
Syringes + tablets, Subcutaneous + Oral, 40 mg, once daily, 5 weeks
Other Names:
Lovenox®Drug: Apixaban + Placebo
Tablet + Syringes, Oral + Subcutaneous, 2.5 mg, twice daily, 5weeks
Other Names:
  • BMS-562247
  • Lovenox®
Study Arm (s)
  • Active Comparator: A1
    + placebo
  • Experimental: A2
    + placebo

Recruitment Information[ + expand ][ + ]

Recruitment StatusCompleted
Estimated Enrollment5407
Estimated Completion DateSeptember 2009
Estimated Primary Completion DateSeptember 2009
Eligibility Criteria
Inclusion Criteria:

- men and non-pregnant, non breastfeeding women

- 18 years or older

- scheduled for hip replacement surgery

Exclusion Criteria:

- hereditary or acquired bleeding disorders

- clotting disorders

- bleeding or high risk for bleeding

- drugs that affect bleeding or coagulation
GenderBoth
Ages18 Years
Accepts Healthy VolunteersNo
ContactsNot Provided
Location CountriesUnited States, Argentina, Australia, Belgium, Canada, China, Denmark, France, Germany, Hungary, India, Israel, Mexico, Norway, Poland, Romania, Russian Federation, Spain, Sweden, Ukraine, United Kingdom

Administrative Information[ + expand ][ + ]

NCT Number NCT00423319
Other Study ID NumbersCV185-035
Has Data Monitoring CommitteeYes
Information Provided ByBristol-Myers Squibb
Study SponsorBristol-Myers Squibb
CollaboratorsNot Provided
Investigators Study Director: Bristol-Myers Squibb Bristol-Myers Squibb
Verification DateMarch 2014

Locations[ + expand ][ + ]

Capstone Clinical Trials, Inc
Birmingham, Alabama, United States, 35209
West Alabama Research, Llc
Birmingham, Alabama, United States, 35209
Martin Bowen Hefley Orthopedics
Little Rock, Arkansas, United States, 72205
Orthoarkansas, P.A.
Little Rock, Arkansas, United States, 72205
Uc Davis Medical Center
Sacramento, California, United States, 95817
Colorado Orthopedic Consultants, Pc
Aurora, Colorado, United States, 80012
Advanced Orthopedic And Sports Medicine Specilists
Denver, Colorado, United States, 80230
Denver-Vail Orthopedics, P.C.
Denver, Colorado, United States, 80230
Pab Clinical Research
Brandon, Florida, United States, 33511
Research Alliance, Inc.
Clearwater, Florida, United States, 33756
Shrock Orthopedic Research
Ft. Lauderdale, Florida, United States, 33316
Phoenix Clinical Research, Llc
Tamarac, Florida, United States, 33321
Atlanta Knee And Sports Medicine
Decatur, Georgia, United States, 30033
Americana Orthopedics
Boise, Idaho, United States, 83702
Bosie Orthopedic Clinic
Meridian, Idaho, United States, 83642
University Orthopedic Center
Altoona, Pennsylvania, United States, 16602
Robert R. King, Md
Lubbock, Texas, United States, 79410
Gill Orthopedic Center
Lubbock, Texas, United States, 79410
Unlimited Research
San Antonio, Texas, United States, 78217
Local Institution
Capital Federal, Buenos Aires, Argentina, C1280AEB
Local Institution
Capital Federal, Buenos Aires, Argentina, C1425AGP
Local Institution
Capital Federal, Buenos Aires, Argentina, C1199ACK
Local Institution
Ciudad De Buenos Aires, Buenos Aires, Argentina, C1426BOS
Local Institution
Coronel Suarez, Buenos Aires, Argentina, B7540GHD
Local Institution
Monte Grande, Buenos Aires, Argentina, B1842DID
Local Institution
Camperdown, New South Wales, Australia, 2050
Local Institution
Kogarah, New South Wales, Australia, 2217
Local Institution
Lismore, New South Wales, Australia, 2480
Local Institution
Southport, Queensland, Australia, 4215
Local Institution
Bedford Park, South Australia, Australia, 5042
Local Institution
Box Hill, Victoria, Australia, 3128
Local Institution
Malvern, Victoria, Australia, 3144
Local Institution
Windsor, Victoria, Australia, 3181
Local Institution
Perth, Western Australia, Australia, 6000
Local Institution
Antwerp, Belgium, 2020
Local Institution
Brasschaat, Belgium, 2930
Local Institution
Genk, Belgium, 3600
Local Institution
Hasselt, Belgium, 3500
Local Institution
Leuven, Belgium, 3000
Local Institution
Edmonton, Alberta, Canada, T6G 2B7
Local Institution
Ajax, Ontario, Canada, L1S 2J5
Local Institution
Cambridge, Ontario, Canada, N1R 7L7
Local Institution
Chatham, Ontario, Canada, N7L 4T1
Local Institution
Guelph, Ontario, Canada, N1E 6L9
Local Institution
Newmarket, Ontario, Canada, L3Y 5G8
Local Institution
Oshawa, Ontario, Canada, L1J 2J2
Local Institution
Sarnia, Ontario, Canada, N7T 6H3
Local Institution
Scarborough, Ontario, Canada, M1S 4T7
Local Institution
St. Catharines, Ontario, Canada, L2R 7P3
Local Institution
Stratford, Ontario, Canada, N5A 2N4
Local Institution
Waterloo, Ontario, Canada, N2J 1C4
Local Institution
Windsor, Ontario, Canada, N8W 1E6
Local Institution
Montreal, Quebec, Canada, H3G 1A4
Local Institution
Quebec, Canada, G1L 3L5
Local Institution
Beijing, Beijing, China, 100853
Local Institution
Beijing, Beijing, China, 100035
Local Institution
Guangzhou, Guangdong, China, 510405
Local Institution
Qingdao, Shandong, China, 266003
Local Institution
Shanghai, Shanghai, China, 200025
Local Institution
Shanghai, Shanghai, China, 200233
Local Institution
Shanghai, Shanghai, China, 200011
Local Institution
Amager, Denmark, 2300
Local Institution
Frederiksberg, Denmark, 2000
Local Institution
Herlev, Denmark, 2730
Local Institution
Horsholm, Denmark, 2970
Local Institution
Hvidovre, Denmark, 2650
Local Institution
Kobenhavn Nv, Denmark, 2400
Local Institution
Silkeborg, Denmark, 8600
Local Institution
Nice, France, 06200
Local Institution
Paris, France, 75019
Local Institution
Paris, France, 75679
Local Institution
Paris, France, 75014
Local Institution
Saint Etienne, France, 42100
Local Institution
Saint-Saulve, France, 59880
Local Institution
Frankfurt, Germany, 60528
Local Institution
Frankfurt / Main, Germany, 65929
Local Institution
Rheinfelden, Germany, 79618
Local Institution
Budapest, Hungary, 1081
Local Institution
Kecskemet, Hungary, 6000
Local Institution
Szeged, Hungary, 6720
Local Institution
Szolnok, Hungary, 5000
Local Institution
Ahmedabad, Gujarat, India, 380015
Local Institution
Ludhiana, Punjab, India, 141001
Local Institution
Lucknow, Uttar Prsdesh, India, 226003
Local Institution
Bangalore, India, 560034
Local Institution
Mangalore, India, 575001
Local Institution
Beer Sheva, Israel, 84101
Local Institution
Haifa, Israel, 31096
Local Institution
Holon, Israel, 58100
Local Institution
Kfar-Saba, Israel, 44281
Local Institution
Zerifin, Israel, 70300
Local Institution
Tijuana, Baja California, Mexico, 22010
Local Institution
Mexico City, Distrito Federal, Mexico, 07760
Local Institution
Mexico City, Distrito Federal, Mexico, 06726
Local Institution
Guadalajara, Jalisco, Mexico, 45235
Local Institution
Monterrey, Nuevo Leon, Mexico, 64460
Local Institution
Cd. Madero, Tamaulipas, Mexico, 89240
Local Institution
Aguascalientes, Mexico, 20010
Local Institution
Chihuahua, Mexico, 31020
Local Institution
Gjettum, Norway, 1346
Local Institution
Kongsvinger, Norway, 2212
Local Institution
Lillehammer, Norway, 2629
Local Institution
Tonsberg, Norway, 3116
Local Institution
Tynset, Norway, 2500
Local Institution
Gdansk, Poland, 80-803
Local Institution
Lodz, Poland, 91-002
Local Institution
Szczecin, Poland, 71-252
Local Institution
Warszawa, Poland, 03-242
Local Institution
Warszawa, Poland, 02-005
Local Institution
Wroclaw, Poland, 50-556
Local Institution
Bucharest, Romania, 021659
Local Institution
Cluj Napoca, Romania, 400132
Local Institution
Chelyabinsk, Russian Federation, 454021
Local Institution
Kazan, Russian Federation, 420029
Local Institution
Moscow, Russian Federation, 119415
Local Institution
Moscow, Russian Federation, 115522
Local Institution
Moscow, Russian Federation, 117292
Local Institution
Moscow, Russian Federation, 111539
Local Institution
Saint Petersburg, Russian Federation, 194354
Local Institution
Saint Petersburg, Russian Federation, 195427
Local Institution
Saint Petersburg, Russian Federation, 196247
Local Institution
Saint Petersburg, Russian Federation, 193312
Local Institution
Saint Petersburg, Russian Federation, 199106
Local Institution
Samara, Russian Federation, 443095
Local Institution
St.Petersburg, Russian Federation, 192242
Local Institution
Yaroslavl, Russian Federation, 150003
Local Institution
Badalona-Barcelone, Spain, 08916
Local Institution
Barcelona, Spain, 08036
Local Institution
Barcelona, Spain, 08035
Local Institution
Barcelona, Spain, 08024
Local Institution
Barcelona, Spain, 08006
Local Institution
Gothenburg, Sweden, 416 85
Local Institution
Stockholm, Sweden, 182 88
Local Institution
Cherkassy, Ukraine, 18009
Local Institution
Chernivtsy, Ukraine, 58013
Local Institution
Dnipropetrovsk, Ukraine, 49005
Local Institution
Ivano-Frankivsk, Ukraine, 76008
Local Institution
Kyiv, Ukraine, 01601
Local Institution
Kyiv, Ukraine, 04107
Local Institution
Sevastopol, Ukraine, 99018
Local Institution
London, Greater London, United Kingdom, SE5 9RS
Local Institution
Wigan, Lancashire, United Kingdom, WN6 9EP
Local Institution
Epsom, Surrey, United Kingdom, KT18 7EG